chevron_leftBack
As of 14 June 2026, Beijing Foyou Pharma CO.,LTD has a market cap of $467.96M USD, ranking #15576 globally and #4885 in China.
It ranks #1388 in the Healthcare sector, and #511 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$467.96MUSD
3.17B CNY
Enterprise Value
$1.11BUSD
7.48B CNY
Revenue (TTM)
$514.34MUSD
3.49B CNY
EBITDA (TTM)
$85.18MUSD
576.47M CNY
Net Income (TTM)
$64.07MUSD
434.14M CNY
EBITDA Margin
17%
Profit Margin
12%
PE Ratio
22.1
PS Ratio
2.8
PB Ratio
2.5
EV/EBITDA
12.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
He Huang
open_in_new
Employees
3,644
Founded
1999
Website
foyou.com.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.5% | -7.2% | -12% | -25% | -6.9% | 33% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
601089
北京福元医药股份有限公司 Class A
ISIN: CNE100005QF9
Shares Out.:
Shares Outstanding:
193.346M1
Shares Float:
48.999M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
20.59 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Beijing Foyou Pharma CO.,LTD
Beijing Foyou Pharma CO.,LTD engages in the research and development, production, and sale of pharmaceutical preparations and medical devices China and internationally. The company provides chemical drugs and traditional chinese medicines. Its products used in cardiovascular kind, chronic kidney disease, skin disease, digestive system, diabetes, neuropsychiatric system kind, mental nervous system, gynecology, and other therapeutic areas. It also offers disposable oxygen and heart blood tube, sugar urine sick, and other products. Beijing Foyou Pharma CO.,LTD was founded in 1999 and is headquartered in Beijing, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
11K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
11K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
6K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
4K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
3K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
3K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
163K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
117K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
77K%
|
97.4
|
|
SIX: RO
|
$321.52B
69K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
62K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
59K%
218.9B CHF
|
20.5
|
chevron_leftBack